BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT06855225-completion@plaintrial.com
DTSTAMP:20261029T005732Z
DTSTART;VALUE=DATE:202805
SUMMARY:A Phase II Study of Single Tremelimumab With Regular Interval Durva
 lumab Plus Gemcitabine and Cisplatin in Locally Advanced Unresectable/Meta
 static Combined Hepatocellular-cholangiocarcinoma — estimated completion
  date
DESCRIPTION:Not yet recruiting. Saved on your PlainTrial shortlist. Full tr
 ial record: https://plaintrial.com/trial/NCT06855225
URL:https://plaintrial.com/trial/NCT06855225
END:VEVENT
END:VCALENDAR